农药创制过程中的经济学评价工具应用探讨  

Discussion over the Method of Economics during Pesticide R & D

作　　者：陈玉明[1] 陈鸣[2] 

机构地区：[1]苏州市第七人民医院,江苏苏州215151 [2]南京医科大学第二附属医院,南京210011

出　　处：《现代农药》2009年第6期44-46,共3页MODERN AGROCHEMICALS

摘　　要：中国农药行业虽然取得了令人瞩目的成绩,但行业创新发展仍停留在较低层次,新产品推出数量和质量与世界水平相比还有较大差距。医药行业研发过程中的药物经济学评价方法已经有效提升了研发工作,对类似的农药创制也有很好的借鉴意义。在新农药创制过程中,通过总成本和总效益分析,设立节点控制标准,能够有效降低研发风险,及时退出没有产业化前景产品的创制,提升产品市场竞争能力和产品生命周期。There has been significant progress in China pesticides industry, but the innovation still stays at a lower level. The abilities of R ＆ D in pesticide are not on high side and there are big differences in the quantities and qualities of new products compared with the leaders in the world. Pharmaceutical economics （PE） has helped to improve the R ＆ D of pharmaceuticals. By use of the PE the total costs and total benefits can be analysed in order to lower the risks of pesticide R ＆ D. The products will be popular by PE analysis in the future.

关 键 词：农药创制 药物经济学 成本 效益 风险控制 

分 类 号：F426.72[经济管理—产业经济]